Voter insights: Four things to know
The 2024 elections are well underway, and we’re continuing to track insights voters are sharing about their priorities and the issues that matter most to them.
The 2024 elections are well underway, and we’re continuing to track insights voters are sharing about their priorities and the issues that matter most to them.
The 2024 elections are well underway, and we’re continuing to track insights voters are sharing about their priorities and the issues that matter most to them. To address the issues voters truly care about, candidates should look at the challenges with the broader health care system, like insurer and PBM practices and other barriers to care – not fixate on an issue that falls to the bottom of voters’ priority lists.
Here are four things you should know:
1. Issues like the economy are top of mind for voters.
2. When it comes to health care, voters are concerned with harmful insurance practices and rising out-of-pocket costs.
Like millions of Americans, we’ve had to fight against harmful prior authorization requirements just to get approval for the doctor-prescribed inhalers my son needs. Every year, we have to renew his prior authorization, and we are often forced to change medications back to ones that have already proven to be ineffective for him. This constant back-and-forth puts a tremendous strain on our family and makes it harder to maintain the care my son needs. – Caregiver, Jason Miller (Billings Gazette)
3. Focusing solely on prescription drug costs overlooks the real concerns voters have with their health care.
As an independent pharmacist, I enjoy serving the patients that come through my doors and connecting them with the critical medications they need. It is upsetting to see so many of these patients, members of my community, struggle to afford or even access their doctor-prescribed medications due to the unfair policies that insurers and their pharmacy benefit managers (PBMs) enforce. – Pharmacist, Joey Entrekin (Times-Georgian)
4. Voters want policymakers to address harmful insurer and middlemen practices and protect access to medicines and treatments.